FDA upgrades recalled broccoli to highest level

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...
The number of hospitalizations and deaths from foodborne illness doubled last year compared to 2023 in the U.S.
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
Recalls on a brand of broccoli and chocolate from December were recently upgraded to Class I, the highest risk level issued ...
The US Food and Drug Administration signed off on the first new type of pain reliever to be approved in more than two decades ...
Following a recall of grounding pads produced by Megadyne, a machinery industry company, the FDA is notifying veterinarians ...
The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...
TUESDAY, Feb. 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the first-ever clinical ...
The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...
A device long used by adults to manage migraines was now available for children as young as eight years old, offering new ...